https://orcid.org/0000-0003-1786-6962
Figures & data
Table 1. Baseline demographics and characteristics for clinical trial patients with PPD contributing to analytic sample (n = 127).
Table 2. Comparison of baseline SF-36v2 Health Survey Scale scores between patients with PPD and adjusted general population norms.
Table 3. Mean and categorical changes in SF-36v2 scale scores from baseline to day 7 and to day 30 by HAMD-17 clinical response status.
Figure 1. Comparison of day 7 (A) and day 30 (B) SF-36v2 Health Survey scale scores between patients with PPD stratified by clinical response status and age- and gender-adjusted general population norms. *p < .05. Abbreviations. PF, physical functioning; RP, role physical; BP, bodily pain; GH; general health; VT, vitality; SF, social functioning; RE, role emotional; MH, mental health; PCS, physical component summary; MCS, mental component summary; HAMD-17, 17-item Hamilton Rating Scale for Depression; PPD, postpartum depression
Table 4. Item content-based interpretation of SF-36v2 scales most related to mental health status by HAMD-17 clinical response status.
Table 5. Estimates of baseline, day 7, and day 30SF-36v2 mental health component summary score distributions and corresponding estimates of visits to psychiatrist or psychologist in the last 6 months and missed work days.